Impaired anti-inflammatory function of apolipoprotein A-II concentrations predicts metabolic syndrome and diabetes at 4 years follow-up in elderly Turks

Creative Commons License

ONAT A., Hergenc G., AYHAN E., UGUR M., Can G.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, cilt.47, sa.11, ss.1389-1394, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 11
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1515/cclm.2009.310
  • Dergi Adı: CLINICAL CHEMISTRY AND LABORATORY MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1389-1394
  • Anahtar Kelimeler: apolipoprotein A-II, coronary heart disease, diabetes, metabolic syndrome, proinflammatory state, CORONARY-ARTERY-DISEASE, INSULIN-RESISTANCE, SERUM ADIPONECTIN, TRANSGENIC MICE, RISK, CHOLESTEROL, LIPOPROTEIN, PLASMA, HDL, ASSOCIATION
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Background: We evaluated prospectively the predictive value of serum apolipoprotein (apo) A-II, the second major apolipoprotein of high-density lipoprotein (HDL), for cardiometabolic risk in Turkish adults showing abnormalities in other proteins that normally confer protection.